Metraipolis › archive › dc_93ef2bce64f5

Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trial — Europe PMC PMID:40857084

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40857084
DOI
10.1002/ejhf.3799
License (as archived)
solo-consultazione
Archived
2026-11-10T08:22:50.859Z
SHA-256 of the archived text
4d1d7f845d32db53bc0eb55c30cbb0e359de510a5d2ce969f20f1b1ee8edabe5
Stable URL of this page
https://metraipolis.com/documento/dc_93ef2bce64f5

How to cite

Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trial — Europe PMC PMID:40857084 — Europe PMC (en), https://europepmc.org/article/MED/40857084 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_93ef2bce64f5 (Metraipolis archive dc_93ef2bce64f5, sha256 4d1d7f845d32db53bc0eb55c30cbb0e359de510a5d2ce969f20f1b1ee8edabe5)
BibTeX
@misc{dc93ef2bce64f5,
  title = {Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trial — Europe PMC PMID:40857084},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40857084},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_93ef2bce64f5; sha256 4d1d7f845d32db53bc0eb55c30cbb0e359de510a5d2ce969f20f1b1ee8edabe5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40857084. Agents can read the archived copy with the MCP tool read_document.